<SEC-DOCUMENT>0000950170-25-072013-index.html : 20250515 <SEC-HEADER>0000950170-25-072013.hdr.sgml : 20250515 <ACCEPTANCE-DATETIME>20250515080011 ACCESSION NUMBER: 0000950170-25-072013 CONFORMED SUBMISSION TYPE: SCHEDULE 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20250515 DATE AS OF CHANGE: 20250515 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Oruka Therapeutics, Inc. CENTRAL INDEX KEY: 0000907654 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 363855489 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-51477 FILM NUMBER: 25948797 BUSINESS ADDRESS: STREET 1: 855 OAK GROVE AVE. STREET 2: SUITE 100 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-606-7910 MAIL ADDRESS: STREET 1: 855 OAK GROVE AVE. STREET 2: SUITE 100 CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: ARCA biopharma, Inc. DATE OF NAME CHANGE: 20090128 FORMER COMPANY: FORMER CONFORMED NAME: NUVELO INC DATE OF NAME CHANGE: 20030203 FORMER COMPANY: FORMER CONFORMED NAME: HYSEQ INC DATE OF NAME CHANGE: 19970610 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: RTW INVESTMENTS, LP CENTRAL INDEX KEY: 0001493215 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G BUSINESS ADDRESS: STREET 1: 40 10TH AVENUE STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 646-597-6980 MAIL ADDRESS: STREET 1: 40 10TH AVENUE STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: RTW INVESTMENTS, LLC DATE OF NAME CHANGE: 20100602 </SEC-HEADER> <DOCUMENT> <TYPE>SCHEDULE 13G <SEQUENCE>1 <FILENAME>primary_doc.xml <TEXT> Document 1 - file: primary_doc.html
Document 1 - RAW XML: primary_doc.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>ck0001669811-ex99_1.pdf <DESCRIPTION>EX-99.1 <TEXT> Document 2 - file: ck0001669811-ex99_1.pdf
</DOCUMENT> </SEC-DOCUMENT>